Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

Share Price is delayed by 15 minutes
Get Live Data
160.00    0.00 (0.00%)
Bid:
120.00
Ask:
200.00
Spread: 80.00 (66.667%)
Market Cap: £77.39m
SPSC Live PriceLast checked at - London Stock Exchange

Intraday Spectra (di/ S) Share Chart

Polymer Banknote Substrate Supply Agreement

1 Aug 2019 07:00

RNS Number : 4552H
Spectra Systems Corporation
01 August 2019
 

Spectra Systems Corporation ("Spectra")

Polymer Banknote Substrate Supply Agreement

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

Spectra Systems Corporation, a leader in machine-readable high speed banknote authentication, brand protection technologies, and gaming security software, is pleased to announce that it has executed a 10 year, renewable by mutual consent, Supply Agreement with a large, technologically driven, global supplier of Biaxially Oriented Polypropylene ("BOPP") for use as a highly covert banknote substrate which is UV dull and maintains the extremely low haze levels required for the signature window security of polymer notes.

Polymer substrates offer increased wear resistance, but traditionally have been viewed as less secure for higher value denominations as opposed to paper, which can have covert security features within the banknote substrate. BOPP polymer banknotes are used in lower denominations in many countries worldwide, and for all denominations in several countries including Australia, Canada and, anticipated in time, the United Kingdom.

Spectra has developed a secure polymer substrate through cooperation with the supplier of BOPP. This partnership and the Supply Agreement will give Spectra the ability to supply more than 2 billion notes per year immediately with additional supply volumes as high as 10 billion banknotes per year to follow. The level III polymer technology has been fully production qualified and sensors have been developed which operate at speeds of 15m/second, 50% faster than the fastest transports currently available. The technology has the capability to create a number of specific covert signatures for different central bank customers.

Dr. Nabil Lawandy, Chief Executive Officer, stated: "We are extremely pleased to have formed a long term partnership with a major multinational supplier of high performance BOPP to bring disruptive new capabilities to the industry and extend our revenue generation potential by combining our core competence in covert security with higher priced polymer substrates. We have created a secure supply chain which can provide substrate with or without opacity and anti-static layers and will be featuring this technology at the upcoming Banknote 2020 conference in Washington DC."

Enquiries:

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer Tel: +1 (0) 401 274 4700

 

WH Ireland Limited

Chris Fielding, Managing Director, Corporate Finance Tel: +44 (0) 20 7220 1650

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRWGUACMUPBGQG
Date   Source Headline
21st Mar 202311:44 amRNSDividend Record Date
20th Mar 20237:00 amRNSAudited results for year ended 31 December 2022
16th Mar 20234:35 pmRNSExercise of Options
6th Mar 202310:39 amRNSRemoval of Reg S restrictions from common stock
11th Oct 20226:12 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSContract Amendment to a Central Bank
21st Sep 20227:00 amRNSExercise of Options
12th Sep 20227:05 amRNSAppointment of Non-Executive Director
12th Sep 20227:00 amRNSInterim Results for Six Months Ended 30 June 2022
16th Aug 20227:00 amRNSFirst Banknote Disinfection System Sold
15th Aug 20227:00 amRNSNew Central Bank Contract Amendment
28th Jul 20227:00 amRNSShare Buy-Back
1st Jul 20222:31 pmRNSShare Buy-Back
28th Jun 20227:00 amRNSShare Buy-Back
15th Jun 20227:00 amRNSAdditional Central Bank Development Revenues
14th Jun 20227:00 amRNSAppointment of Chief Financial Officer
13th Jun 20227:00 amRNSAnnual General Meeting Update
25th May 20227:00 amRNSExercise of Options and Director/PDMR Shareholding
20th May 20228:44 amRNSRemoval of Regulation S restrictions from shares
20th May 20228:41 amRNSResignation of Chief Financial Officer
3rd May 20227:00 amRNSPosting of Annual Report & Notice of AGM
6th Apr 20221:36 pmRNSRemoval of Reg S restrictions from common stock
28th Mar 20227:00 amRNSGrant of Share Options
21st Mar 20227:00 amRNSResults twelve months ended 31 December 2021
24th Jan 20227:00 amRNSNew contract awards
21st Jan 20227:00 amRNSExercise of Options
6th Dec 20217:00 amRNSNew K-cup Orders in Q4 Exceed Expectations
2nd Nov 20213:37 pmRNSExercise of Options
25th Oct 20214:18 pmRNSRemoval of Regulation S restrictions
11th Oct 20217:00 amRNSLarge Central Bank Order
13th Sep 202110:27 amRNSHolding(s) in Company
25th Aug 202111:23 amRNSRemoval of Regulation S restrictions
21st Jul 20217:00 amRNSBanknote cleaning system also deactivates Covid-19
14th Jun 20217:00 amRNSAnnual General Meeting Update
17th May 20215:12 pmRNSShare Buy-Back
7th May 20214:49 pmRNSShare Buy-Back
6th May 20212:58 pmRNSShare Buy-Back
4th May 20215:51 pmRNSPosting of Annual Report and Accounts, AGM Notice
26th Apr 20211:45 pmRNSExercise of Options
22nd Apr 20217:00 amRNSNew Lottery Contracts
21st Apr 20217:00 amRNSEnhanced sensor capability contract
19th Apr 20211:46 pmRNSExercise of Options
8th Apr 20217:00 amRNSAllowance of Banknote Disinfection Patent
1st Apr 20213:29 pmRNSExercise of Options and Director/PDMR Shareholding
22nd Mar 20217:35 amRNSAudited Results for the 12 months ended 31 Dec 20
10th Feb 20217:00 amRNSExercise of Options
9th Feb 20212:11 pmRNSAppointment of Director
2nd Feb 20217:00 amRNSSecond phase of contract for sensor development
1st Feb 20213:33 pmRNSExercise of Options
20th Jan 20217:00 amRNSExercise of Options and Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.